Chris Chorley

Regulatory Program Director at Roche

Speaker

Chris has worked in the pharmaceutical industry for approximately 20 years. He began his career at AstraZeneca in 2008, initially working as a synthetic organic chemist, before moving into the CMC regulatory compliance group in 2011. Following roles with Pharmalink Consulting and Ipsen, Chris moved to Biogen in 2020, where he led regulatory CMC activities for small molecule and oligonucleotide programs at various development stages. Chris joined Roche in March 2026 as a Regulatory Program Director for new modalities. He holds a master’s degree in chemistry from the University of York, UK.